Rheumatism encompasses over 200 conditions causing chronic joint pain. Term "rheumatism" originates from Greek "to suffer from bodily fluids". Rheumatology is the medical branch specializing in rheumatic disorders
Fourth edition reflects changing face of rheumatic diseases. Provides evidence-based treatment approaches across all age groups. Includes clinical vignettes and emphasizes interdisciplinary collaboration
Bimzelx contains bimekizumab for treating inflammatory diseases. Reduces inflammation in psoriasis, psoriatic arthritis, axial spondyloarthritis and hidradenitis suppurativa. Works by inhibiting IL-17A and IL-17F proteins involved in inflammation
Otezla treats moderate to severe plaque psoriasis in adults. Used for psoriatic arthritis when other treatments fail. Approved for Behçet's disease mouth ulcers. Available as 10, 20 or 30 mg tablets
Naproxen available in 250mg, 375mg, and 500mg tablets. EC-NAPROSYN contains 375mg and 500mg naproxen in enteric-coated form. ANAPROX available in 275mg and 550mg naproxen sodium tablets. NAPROSYN suspension contains 125mg naproxen per 5mL
EULAR and ACR collaborate on international initiatives for clinical trials. 2025 proposal call for proposals is now open. Annual deadline for proposal submissions between organizations